Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06432985 · ClinicalTrials.gov registry record · NA

Smoking Cessation CM for Veterans With or at Risk for Cancer

A NA study of Tobacco Use Disorder and Substance Use Disorder, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT06432985 is a NA study of Tobacco Use Disorder and Substance Use Disorder that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 108 participants, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06432985, a NA study of Tobacco Use Disorder and Substance Use Disorder, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

Tobacco use among US Veterans poses significant health problems and challenges to their overall well-being. The aim of this project is to evaluate the effectiveness of a program called Contingency Management (CM) in helping Veterans quit smoking during lung cancer screening or cancer care at VA clinics. CM is a behavioral treatment that uses rewards to encourage smoking cessation when verified through biological testing. In the first year, the researchers will develop a mobile CM protocol based on feedback from Veterans and healthcare staff through focus groups. In the second year, they will conduct a pilot study to test the feasibility of the mobile CM program along with counseling and medication for 20 Veterans over a five-week period. The success of the pilot study will determine whether to proceed with a larger randomized controlled trial (RCT) in years three to six, comparing the efficacy of mobile CM with standard treatment. The project will take place at SFVA.

Interventions

  • BEHAVIORAL Focus Group
  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Behavioral Counseling (Cognitive Behavioral Therapy, CBT)
  • BEHAVIORAL TUD Treatment as Usual (TAU)

Study Locations (1)

California

  • San Francisco VA Medical Center, San Francisco, CA - San Francisco

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2025-01-29
Est. Completion 2031-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT06432985

The ClinicalTrials.gov registry entry for NCT06432985 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (55% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Focus Group is the first listed.

NCT06432985 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06432985 about?

NCT06432985 is a clinical study titled "Smoking Cessation CM for Veterans With or at Risk for Cancer". Tobacco use among US Veterans poses significant health problems and challenges to their overall well-being. The aim of this project is to evaluate the effectiveness of a program called Contingency Management (CM) in helping Veterans quit smoking during lung cancer screening or cancer care at VA clin...

What is the current status of trial NCT06432985?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-01-29. Estimated completion is 2031-09-30.

What conditions does trial NCT06432985 study?

This clinical trial studies the following conditions: Tobacco Use Disorder, Substance Use Disorder.

What interventions are being tested in trial NCT06432985?

The interventions under investigation include: Focus Group (BEHAVIORAL), Contingency Management (BEHAVIORAL), Behavioral Counseling (Cognitive Behavioral Therapy, CBT) (BEHAVIORAL), TUD Treatment as Usual (TAU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06432985?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06432985 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.